Five Traditional Nigerian Polyherbal Remedies Protect Against High Fructose Fed, Streptozotocin-induced Type 2 Diabetes in Male Wistar Rats
Overview
Authors
Affiliations
Background: This present study sought to assess the modulatory effects of five Nigerian traditional polyherbal in high fructose-fed, streptozotocin-induced (HF-STZ) Type 2 diabetes (T2D) in rats. T2D was achieved via fructose feeding (20%) ad libitum for 2 weeks and streptozotocin (STZ, 40 mg/kg) (15th Day) intraperitoneally.
Methods: Seventy-two hours after STZ injection, fourty-eight diabetic rats were divided into eight of 6 rats/group: Diabetic normal untreated, glibenclamide (GBLI, 0.07 mL/kg) or yoyo (YB, 0.43), ruzu (RB, 0.08), fajik (FJB, 0.20), oroki (OB, 0.16), and fidson (FB, 0.43)/ mL/kg bitters respectively. Controls normal and diabetic untreated groups received intragastric carboxylmethylcellulose (CMC, 1 mL/kg) for eleven days.
Results: T2D was characterized in rats by an increased (p < 0.001-0.05) blood glucose levels (BGL), total cholesterol, triglycerides, low-density lipoprotein and alanine aminotransferase compared with control CMC group. Similarly, hepatic and pancreatic malondialdehyde (MDA) were increased by 180 and 97% respectively. Polyherbal treatments demonstrated efficacies on BGL as follow: YB (55.6%, 160.7 mg/dL); RB (59.7%, 145.2 mg/dL); FJB (59.8%, 243.4 mg/dL); OB (60.8%, 194.5 mg/dL) and FB (61.3%, 203.3 mg/dL) respectively by day 11 (versus GBLI, 65.1%) compared with control untreated diabetic rats. Also, elevated TC, LDL cholesterol, ALT were lowered (p < 0.05) by YB, FJB, and FB respectively in rats. YB, FJB, and OB lowered MDA levels in treated rats. Further, YB, RB, FJB and FB restored changes in liver, and pancreas histopathology. Predominant non-polar bioactive include oleic, hexadecanoic, octadecanoic among others following gas chromatography-mass spectrophotometry analyses.
Conclusion: Overall, these present results demonstrate anti-hyperglycemic potentials, although with cautions, of some polyherbal in T2D rats, which may, in part, be antioxidants mediated.
Ogunyemi O, Gyebi G, Olawale F, Ibrahim I, Iwaloye O, Fabusiwa M Bioinform Adv. 2025; 5(1):vbae205.
PMID: 39846080 PMC: 11751579. DOI: 10.1093/bioadv/vbae205.
Lattibeaudiere K, Alexander-Lindo R Adv Pharmacol Pharm Sci. 2024; 2024:5556722.
PMID: 38938594 PMC: 11208809. DOI: 10.1155/2024/5556722.
Cao M, Li Y, Famurewa A, Olatunji O Diabetes Metab Syndr Obes. 2021; 14:2121-2131.
PMID: 34012278 PMC: 8126874. DOI: 10.2147/DMSO.S302748.
Subacute and subchronic oral toxicity assessments of (DC.) Guill. & Perr. root in Wistar rats.
Kale O, Awodele O, Akindele A Toxicol Rep. 2019; 6:161-175.
PMID: 30766799 PMC: 6360914. DOI: 10.1016/j.toxrep.2019.01.005.
Awodele O, Badru W, Busari A, Kale O, Ajayi T, Udeh R BMC Pharmacol Toxicol. 2018; 19(1):68.
PMID: 30359320 PMC: 6202817. DOI: 10.1186/s40360-018-0253-y.